» Articles » PMID: 1651412

Initiation of Transcription from the Minute Virus of Mice P4 Promoter is Stimulated in Rat Cells Expressing a C-Ha-ras Oncogene

Overview
Journal J Virol
Date 1991 Sep 1
PMID 1651412
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Transformation of FR3T3 rat fibroblasts by a c-Ha-ras oncogene but not by bovine papillomavirus type 1 is associated with an increase in the abundance of mRNAs from prototype strain MVMp of infecting minute virus of mice, an oncosuppressive parvovirus. This differential parvovirus gene expression correlates with the reported sensitization of ras- but not bovine papillomavirus type 1-transformed cells to the killing effect of MVMp (N. Salomé, B. van Hille, N. Duponchel, G. Meneguzzi, F. Cuzin, J. Rommelaere, and J. Cornelis, Oncogene 5:123-130, 1990). Experiments were performed to determine at which level parvovirus expression is up-regulated in ras transformants. An MVMp "attenuation" sequence responsible for the premature arrest of RNA elongation was either placed or not placed in front of the chloramphenicol acetyltransferase gene and brought under the control of MVMp early promoter P4. Although the MVMp attenuator reduced P4-driven chloramphenicol acetyltransferase expression, the extent of attenuation was similar in normal and ras-transformed cells. Moreover, the analysis of P4-directed viral RNAs in MVMp-infected cultures by RNase protection and nuclear run-on assays also revealed a transcription elongation block of a similar amplitude in both types of cells. In addition, the stabilities of the three major parvoviral mRNAs did not vary significantly between normal and ras-transformed cells. Hence, it is concluded that the ras-induced increase in the accumulation of parvoviral mRNAs is mainly controlled at the level of transcription. Consistently, the TATA motif of the P4 promoter proved to have a differential photoreactivity when tested by in vivo UV footprinting assays in ras-transformed versus normal cells.

Citing Articles

Best of most possible worlds: Hybrid gene therapy vectors based on parvoviruses and heterologous viruses.

Fakhiri J, Grimm D Mol Ther. 2021; 29(12):3359-3382.

PMID: 33831556 PMC: 8636155. DOI: 10.1016/j.ymthe.2021.04.005.


The Peroxisomal 3-keto-acyl-CoA thiolase B Gene Expression Is under the Dual Control of PPARα and HNF4α in the Liver.

Chamouton J, Hansmannel F, Bonzo J, Clemencet M, Chevillard G, Battle M PPAR Res. 2011; 2010:352957.

PMID: 21437216 PMC: 3061263. DOI: 10.1155/2010/352957.


Viral oncolysis that targets Raf-1 signaling control of nuclear transport.

Riolobos L, Valle N, Hernando E, Maroto B, Kann M, Almendral J J Virol. 2009; 84(4):2090-9.

PMID: 19939915 PMC: 2812376. DOI: 10.1128/JVI.01550-09.


Exploring the contribution of distal P4 promoter elements to the oncoselectivity of Minute Virus of Mice.

Paglino J, Burnett E, Tattersall P Virology. 2006; 361(1):174-84.

PMID: 17175002 PMC: 1853334. DOI: 10.1016/j.virol.2006.11.006.


A missense mutation in hepatocyte nuclear factor-4 alpha, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus.

Hani E, Suaud L, Boutin P, Chevre J, Durand E, Philippi A J Clin Invest. 1998; 101(3):521-6.

PMID: 9449683 PMC: 508593. DOI: 10.1172/JCI1403.


References
1.
Schoborg R, Pintel D . Accumulation of MVM gene products is differentially regulated by transcription initiation, RNA processing and protein stability. Virology. 1991; 181(1):22-34. DOI: 10.1016/0042-6822(91)90466-o. View

2.
Brandenburger A, Legendre D, Avalosse B, Rommelaere J . NS-1 and NS-2 proteins may act synergistically in the cytopathogenicity of parvovirus MVMp. Virology. 1990; 174(2):576-84. DOI: 10.1016/0042-6822(90)90110-d. View

3.
Grignani F, Lombardi L, Inghirami G, Sternas L, Cechova K, Dalla-Favera R . Negative autoregulation of c-myc gene expression is inactivated in transformed cells. EMBO J. 1990; 9(12):3913-22. PMC: 552162. DOI: 10.1002/j.1460-2075.1990.tb07612.x. View

4.
Berns K . Parvovirus replication. Microbiol Rev. 1990; 54(3):316-29. PMC: 372780. DOI: 10.1128/mr.54.3.316-329.1990. View

5.
Avvedimento V, Musti A, Fusco A, Bonapace M, Di Lauro R . Neoplastic transformation inactivates specific trans-acting factor(s) required for the expression of the thyroglobulin gene. Proc Natl Acad Sci U S A. 1988; 85(6):1744-8. PMC: 279855. DOI: 10.1073/pnas.85.6.1744. View